1 | Case | 1.57% | |
2 | Report | 1.39% | |
3 | Cancer | 1.04% | |
4 | Study | 0.87% | |
5 | New | 0.87% | |
6 | According | 0.7% | |
7 | Disease | 0.7% | |
8 | Renal | 0.52% | |
9 | Dysfunction | 0.52% | |
10 | Carcinoma | 0.52% | |
11 | Review | 0.52% | |
12 | Cell | 0.52% | |
13 | Therapy | 0.52% | |
14 | Treatment | 0.52% | |
15 | Rare | 0.52% | |
16 | Bone | 0.52% | |
17 | Research | 0.52% | |
18 | NSCLC | 0.52% | |
19 | Reconstruction | 0.35% | |
20 | Cervical | 0.35% | |
21 | Loss | 0.35% | |
22 | Patients | 0.35% | |
23 | Receptor | 0.35% | |
24 | Colorectal | 0.35% | |
25 | Infection | 0.35% | |
26 | Advanced | 0.35% | |
27 | Assay | 0.35% | |
28 | Muscle | 0.35% | |
29 | Global | 0.35% | |
30 | Alzheimer’s | 0.35% | |
31 | Skin | 0.35% | |
32 | Health | 0.35% | |
33 | Molecular | 0.35% | |
34 | Mediterranean | 0.35% | |
35 | Randomized | 0.35% | |
36 | Partial | 0.35% | |
37 | Treated | 0.35% | |
38 | Role | 0.35% | |
39 | Adjuvant | 0.35% | |
40 | May | 0.35% | |
41 | ADHD | 0.35% | |
42 | Weight | 0.35% | |
43 | Lower | 0.35% | |
44 | Clinical | 0.35% | |
45 | Not | 0.35% | |
46 | Endometriosis | 0.35% | |
47 | Healthcare | 0.35% | |
48 | U.S. | 0.35% | |
49 | Artery | 0.35% | |
50 | Tract | 0.35% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Gene Expression Profiling as an Emerging Tool in Skin Cancer Management
Dermatology Times
2025-06-01 04:02:47
Examining Tominersen as a Potential Treatment for Huntington Disease: The GENERATION HD2 trial
NeurologyLive
2025-06-01 04:02:21
Gene Therapy, ASOs, and Beyond: What’s Coming for Huntington’s Disease
NeurologyLive
2025-06-01 02:02:21